Adherence to antiretroviral therapy in Africa: How high is it really?

Tropical Medicine and International Health

Volumn 13, Issue 9, 2008, Pages 1096-1097

  Jaffar, Shabbar ^a   Munderi, Paula ^b   Grosskurth, Heiner ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

Author keywords

Adherence; Africa; Antiretroviral; RNA viral load; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; RNA;

ACCURACY; AFRICA; CD4+ T LYMPHOCYTE; COMMUNITY CARE; DEVELOPED COUNTRY; DRUG POTENCY; EDITORIAL; FOLLOW UP; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PATIENT COMPLIANCE; PATIENT COUNSELING; RELIABILITY; SCREENING; SURVIVAL; VIRUS LOAD;

AFRICA; ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HIV-1; HUMANS; PATIENT COMPLIANCE;

EID: 50049099730     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02131.x     Document Type: Editorial

References (19)

1. Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817 824.
2. Brook MG, Dale A, Tomlinson D, Waterworth C, Daniels D Forster G (2001) Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units. AIDS Patient Care STDS 15, 491 494.
3. Coetzee D, Hildebrand K, Boulle A et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. Aids 18, 887 895.
4. Dalal RP, Macphail C, Mqhayi M et al. (2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndrome 47, 101 107.
5. DART Virology Group and Trial Team (2006) Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. Aids 20, 1391 1399.
6. Etard JF, Ndiaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. Aids 20, 1181 1189.
7. Gazzard B (2005) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Medicine 6 (Suppl. 2 S1 S61.
8. Gill CJ, Hamer DH, Simon JL, Thea DM Sabin LL (2005) No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. Aids 19, 1243 1249.
9. IeDEA (2008) Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Medicine and International Health 13, 870 879.
10. Jaffar S, Grant AD, Whitworth J, Smith PG Whittle H (2004) The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bulletin of the World Health Organization 82, 462 469.
11. Laurent C, Diakhate N, Gueye NF et al. (2002) The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. Aids 16, 1363 1370.
12. Marazzi MC, Liotta G, Germano P et al. (2008) Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Research Human Retroviruses 24, 555 560.
13. Mermin J, Were W, Ekwaru JP et al. (2008) Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 371, 752 759.
14. Mills EJ, Nachega JB, Buchan I et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Journal of the American Medical Association 296, 679 690.
15. Orrell C, Bangsberg DR, Badri M Wood R (2003) Adherence is not a barrier to successful antiretroviral therapy in South Africa. Aids 17, 1369 1375.
16. Rosen S, Fox MP Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4, e298.
17. Stringer JS, Zulu I, Levy J et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. Journal of the American Medical Association 296, 782 793.
18. World Health Organization (2008) Towards Universal Access: Scaling up priority HIV/AIDS in the health sector. Progress report. WHO, Geneva.
19. Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bulletin of the World Health Organization 85, 550 554.